-
Erlotinib, sold
under the
brand name
Tarceva among others, is a
medication used to
treat non-small cell lung
cancer (NSCLC) and
pancreatic cancer. Specifically...
-
metastatic breast cancer.
Erlotinib, an anti-tumor agent.
Afatinib for
treatment of
cancers resistant to
gefinitib and
erlotinib.
Quinazolinone Niementowski...
-
Gimatecan Irinotecan Topotecan Etoposide Teniposide Tafluposide Bortezomib Erlotinib Gefitinib Imatinib Vemurafenib Vismodegib Azacitidine Azathioprine Capecitabine...
- breast, lung and
other cancers.
Gefitinib is an EGFR inhibitor, like
erlotinib,
which interrupts signaling through the
epidermal growth factor receptor...
-
Erlotinib (marketed as Tarceva).
Erlotinib inhibits epidermal growth factor receptor, and
works through a
similar mechanism as gefitinib.
Erlotinib has...
-
Mechanical Allergic Facial nerve palsy Anti-cancer
treatments such as
erlotinib, cetuximab, and panitumumab,
which block the
function of EGFR (the epidermal...
-
Nicolson M,
Groves RW, et al. (2009). "Expert
consensus on the
management of
erlotinib-****ociated
cutaneous toxicity in the U.K." Oncologist. 14 (8): 840–7....
-
mutations targeted by
first generation tyrosine-kinase
inhibitors (TKIs) like
erlotinib or gefitinib, but also
against less
common mutations which are resistant...
- its long-term safety.
There are
indications that the lung
cancer drug
erlotinib may be an
additional treatment option for
those with
certain genetic markers...
-
antagonists such as
erlotinib (Tarceva) or
gefitinib (Iressa).
Patients who
harbor an EGFR
mutation have a 60%
response rate to
erlotinib. However, the mutation...
